Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1128.9000 33.20 (3.03%)
NSE Sep 18, 2025 15:56 PM
Volume: 1.8M
 

1128.90
3.03%
Geojit BNP Paribas
EBITDA grew 13.3% YoY, EBITDA margin expanded 100bps to 21.5% mainly due to increased gross margin (+60bps YoY), and partially offset by higher R&D; spends. Net profit surged 4x YoY, on account of...
Aurobindo Pharma Ltd. is trading below its 150 day SMA of 1131.6
More from Aurobindo Pharma Ltd.
Recommended